Recently the concept of using specific inhibitors of endogenous cholesterol synthesis as a means of reducing the cholesterol content of the body has been reviewed (1). One such specific inhibitor is the metal vanadium. Salts of vanadium have been shown to inhibit the utilization of mevalonic acid for cholesterol biosynthesis (2), to inhibit cholesterol biosynthesis in vitro and in vivo (3), to induce mobilization of predeposited aortic cholesterol in rabbits (4) and to lessen the deposition of cholesterol in rabbits (5) and in birds (6) fed high cholesterol diets.To extend these studies to man, the effects of vanadium on sterol balance in normocholesterolemic men under rigid dietary control were examined. The investigations reported here show that, under such conditions, inhibition of endogenous cholesterol biosynthesis with a salt of vanadium produces a lowering of serum cholesterol levels. The studies provide data which suggest that mobilization of tissue cholesterol stores also occurs. C. Experimental design. The men ate an identical diet during the entire study. After a two week control period, each man received diammonium oxy-tartratovanadate1 (B. B., 100 mg.; others, 125 mg.) orally in three divided doses each day for the experimental period of six weeks. During the final recovery period of three weeks the vanadium administration was discontinued.D. Chemical methods. Serum. Fasting blood samples were obtained once each week. Cholesterol (7), phospholipid (8, 9), triglyceride (10), alkaline phosphatase (11) and transaminase (12) serum levels were determined. Serum cholesterol determinations were carried out on duplicate aliquots of sera.Urine. Twenty-four hour samples were collected once each week and daily for the week after cessation of vanadium administration. Vanadium was determined by a colorimetric method (13) (20).Diet. Aliquots of the total 24 hour diet, prepared by homogenization in a Waring Blendor with water, were analyzed for total fat (20) and neutral sterol (7,16,17) content.